EU expands use of Amgen’s Blincyto

30th August 2018 Uncategorised 0

European regulators have expanded the scope of Amgen’s Blincyto to include the treatment of younger patients with a rare type of leukaemia.

More: EU expands use of Amgen’s Blincyto
Source: News